SLP · Simulations Plus, Inc.
Market Cap
$372.74M
Shares
20.22M
SLP metrics
78 of 114 screener metrics currently available.
Market overview
2 metricsShare price
$18.43
Market cap
$372.74M
Price action
19 metricsPrice change (1W)
+0.2%
Price change (30D)
+0.4%
Price change (3M)
+16.1%
Price change (6M)
+50.8%
Price change (YTD)
+1.1%
Price change (1Y)
+30.5%
Trailing year
Price change (5Y)
-59.9%
52-week high
$20.84
52-week low
$11.36
Change from 52-week high
-11.6%
Change from 52-week low
+62.2%
Annualized volatility
47.8%
Beta
1.0
RSI (14D)
64.1
Price vs SMA 50
+0.6%
Price vs SMA 200
+12.8%
Avg volume (3M)
413,449
Relative volume
0.2
Average dollar volume
$7.51M
Company
3 metricsSector
Healthcare
Industry
Health Information Services
Shares outstanding
20.22M
Valuation
12 metricsP / E (TTM)
46.1
Trailing earnings · reciprocal yield 2.2%
PEG ratio
—
EV / revenue
—
EV / EBITDA
—
EV / EBIT
—
P / sales
4.5×
reciprocal yield 22.0%
P / book
2.7
reciprocal yield 37.3%
FCF yield
6.6%
TTM · current market cap
Buyback yield
0.0%
P / FCF
15.2
reciprocal yield 6.6%
P / operating cash flow
14.9
reciprocal yield 6.7%
Earnings yield
2.2%
Historical valuation
8 metricsP / E historical average (3Y)
70.8×
reciprocal yield 1.4%
P / E historical average (5Y)
79.3×
reciprocal yield 1.3%
EV / revenue historical average (3Y)
—
EV / revenue historical average (5Y)
—
EV / EBIT historical average (3Y)
—
EV / EBIT historical average (5Y)
—
EV / EBITDA historical average (3Y)
—
EV / EBITDA historical average (5Y)
—
Dividends & buybacks
7 metricsDividend yield
—
Trailing 12 months
Payout ratio
—
Shareholder yield
—
Dividend / share (TTM)
—
Dividend growth YoY
—
Dividend growth streak
—
Last ex-dividend
2024-07-29
Earnings calendar
2 metricsNext earnings
—
Last earnings
2026-07-09
Profitability
9 metricsGross margin
63.4%
Operating margin
14.0%
Trailing 12 months
Net margin
9.9%
Gross profit (TTM)
$52.01M
Operating profit (TTM)
$11.50M
Net income (TTM)
$8.11M
Trailing 12 months
Diluted EPS (TTM)
$0.40
FCF margin
29.9%
Effective tax rate
35.4%
Growth
11 metricsRevenue growth YoY
+7.5%
Year over year
Net income growth YoY
-750.2%
Revenue (TTM)
$82.06M
Trailing 12 months
EPS growth YoY
-757.1%
Shares change YoY
+0.6%
Year over year · more shares
Revenue CAGR (3Y)
+13.7%
Revenue CAGR (5Y)
+13.7%
EPS CAGR (3Y)
—
EPS CAGR (5Y)
—
FCF CAGR (3Y)
+0.6%
FCF CAGR (5Y)
+10.3%
Quality
14 metricsReturn on equity
5.8%
Return on assets
5.3%
Debt / equity
—
Current ratio
5.5
EBITDA (TTM)
$17.12M
Free cash flow (TTM)
$24.54M
Quick ratio
5.5
Interest coverage
—
Net debt / EBITDA
—
Return on invested capital
—
Trailing 12 months
Net cash
—
Latest balance sheet
Cash & equivalents
$35.32M
Total assets
$152.98M
Total debt
$5.89M
Cash flow & spend
7 metricsOperating cash flow (TTM)
$24.94M
Capital expenditures (TTM)
$403,000
R&D (TTM)
$11.53M
SG&A (TTM)
$17.67M
Stock compensation (TTM)
$6.42M
R&D / revenue
14.1%
Stock compensation / revenue
7.8%
Ownership (13F)
3 metrics13F filers
170
13F filer change QoQ
+9
Institutional ownership
78.3%
Short interest
3 metricsShort interest
13.9%
Latest settlement · 15.8 days to cover
Days to cover
15.8d
Short-squeeze score
73 / 100
Insider activity
2 metricsNet insider buying (90D)
−$264,769
Insider-sentiment score
—
Risk flags
1 metricsGoing concern
—